Blastic transformation of juvenile myelomonocytic leukemia caused by the copy number gain of oncogenic KRAS

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26496. Epub 2017 Feb 28.

Abstract

Previous studies have reported several cases of juvenile myelomonocytic leukemia (JMML) developing blastic transformation during an indolent clinical course, but the underlying mechanism of transformation is still not well understood. In this report, we describe a case of JMML with blastic transformation possibly caused by additional copy number gains of the KRAS mutant allele. We have discovered that the copy number gain of the mutant allele is an additional possible cause of blastic transformation in JMML.

Keywords: CNG; JMML; KRAS; blast crisis; duplication.

Publication types

  • Case Reports

MeSH terms

  • Bone Marrow Transplantation
  • Female
  • Gene Dosage*
  • Humans
  • Infant
  • Leukemia, Myelomonocytic, Juvenile / genetics*
  • Leukemia, Myelomonocytic, Juvenile / therapy
  • Lymphocyte Activation / genetics*
  • Proto-Oncogene Proteins p21(ras) / genetics*

Substances

  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)